India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Third Phase 3 trial in third type of lymphoma to show improvement in overall survival with an ADCETRIS-containing regimen
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
GC1130A has previously achieved notable milestones by securing both RPDD and ODD from the U.S. FDA in January 2023
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Subscribe To Our Newsletter & Stay Updated
